SCHEMBL6913

SCHEMBL6913

C#Cc1cccc(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20464789 1.00
SCHEMBL29739031 1.00
SCHEMBL11384287 0.93 TAAR1 (0.45)
SCHEMBL3892483 0.91 GRM5 (0.44)
SCHEMBL11232059 0.88 GRM5 (0.42)
SCHEMBL28061276 0.88 GRM5 (0.42)
SCHEMBL11230632 0.84 GRM5 (0.40)
SCHEMBL11235736 0.83 GRM5 (0.39)
SCHEMBL1502312 0.81 CA12 (0.54)
SCHEMBL9302636 0.79 CA12 (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 951 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122059955-A Imidazo pyridone compound, photocatalysis continuous synthesis method and application thereof 南京工业大学 2026-05-19 CN claimed
EP-4157898-B1 CHEMICALLY CONVERTED CATALYSTS DOW GLOBAL TECHNOLOGIES LLC (US) 2026-04-29 EP claimed
US-20260008876-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2026-01-08 US claimed
WO-2025128214-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-19 WO claimed
WO-2025128219-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-19 WO claimed
WO-2025128218-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-19 WO claimed
WO-2025128220-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-19 WO claimed
WO-2025128216-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-19 WO claimed
WO-2025128217-A1 ADDITIVE FOR A CATALYST DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-19 WO claimed
CN-120132861-A Copper-based high-entropy alloy material and preparation method and application thereof 温州大学新材料与产业技术研究院 2025-06-13 CN claimed
CN-103299471-A Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery MATSUSHITA ELECTRIC INDUSTRIAL CO LTD 2013-09-11 CN claimed
EP-2013171-B1 PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER S DISEASE MERCK SHARP & DOHME (GB) 2013-05-15 EP claimed
EP-1833791-B1 2,3,4,9-TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2011-08-03 EP claimed
EP-1551834-B1 SUBSTITUTED QUINAZOLINONE COMPOUNDS NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-25 EP claimed
EP-1599201-B1 SELECTIVE NON-STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS MERCK SHARP & DOHME (US) 2010-04-14 EP claimed
EP-1664027-B1 SUBSTITUTED 2,3-DIHYDRO-1H-ISOINDOL-1-ONE DERIVATIVES AND METHODS OF USE AMGEN INC (US) 2009-12-30 EP claimed
EP-1664023-B1 SUSTITUTED ISOQUINOLINE DERIVATIVES AND METHODS OF USE AMGEN INC (US) 2008-08-13 EP claimed
EP-1853595-A1 (1,5-DIPHENYL-1H-PYRAZOL-3-YL)OXADIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS Sanofi-Aventis (FR) 2007-11-14 EP claimed
WO-2006087480-A1 (1,5-DIPHENYL-1H-PYRAZOL-3-YL)OXADIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS SANOFI-AVENTIS (FR) 2006-08-24 WO claimed
EP-1244617-B1 SUBSTITUTED AMINOALKYLAMIDE DERIVATIVES AS ANTAGONISTS OF FOLLICLE STIMULATING HORMONE ORTHO MCNEIL PHARM INC (US) 2005-02-16 EP claimed